Blackrock, Inc.

Location

New York

Founded

1988-02-08

Website

https://www.blackrock.com

Risk Signals

70260 news mentions monitored

Industry Context

This company is tracked across risk categories, including those related to its sector (e.g., Investment Advice, Management Investment Offices, Open-End), including supply chain integrity, ESG practices, labor disputes, and regulatory compliance.

Filter risk signals by topic

Select a theme below to explore the company’s news mentions in specific risk areas.

Activist Short Selling (20) Debt Strategy and Obligations (7) Cryptocurrency Market Analysis (6) Investment Strategies (6) Stock Market Events (5) Political and Economic Developments (4) Corporate Financing Plans (3) Asset Valuation (3) Equity Analysis & Ratings (3) Recruitment Activities (2) Corporate Financial Crises (2) Business Growth Initiatives (2) Fraud Investigations (2) New Product Release (1) Renewable Energy Innovations (1) Acquisition Announcements (1) Sustainable Practices (1) Blockchain Innovations (1) Business Resilience Planning (1) Data Privacy Regulations (1) Economic Indicators (1) Economic Policy Developments (1) Executive Leadership Changes (1) Financial Reporting (1) Funding Announcements (1) Global Diplomacy and Conflicts (1) Insider Trading Violations (1) Investor Activism (1) Legal Proceedings (1)

Recent Articles about Blackrock, Inc.

Live alerts from global media, monitored by Business Radar

2025-05-12 (finanzas.com)

Blackrock bearish offensive against Ibex 35 renewables after the blackout: € 100m in short

Blackrock raises its short positions on Solararia and operates energy until it brushes 100 million euros just after the great blackout

2025-05-01 (investing.com)

Blackrock revealed shares in Mural Oncology PLC according to .com

Investing.com - Investment Management Company Blackrock, Inc. Announced its own shares and position in the Mural Oncology PLC, a company currently in a situation of acquisition managed by the rules of the Irish acquisition committee. As of April 30, 2025, Blackrock held a total of 1.40% of the benefits in Mural Oncology, equivalent to 242,291 ordinary shares. In addition, Blackrock also has a short selling position accounting for 0.41% of the company, equivalent to 71,756 shares.

2025-04-23 (investing.com)

Blackrock reports shares in Mural Oncology by .com

Investing.com - Blackrock, Inc., one of the world's leading investment companies, has published a significant investment in Mural Oncology PLC Biotechnology Company, according to the latest record with the Ireland Task Force. According to the announcement, on April 23, 2025, Blackrock currently owns 1.20% of Mural Oncology's regular shares, along with additional short selling positions accounting for 0.41%.